SB-525
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB-525, covering 2025-09-30 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A [Phase 2]